Family planning and fertility preservation can pose challenges for trainees and new surgical oncology attendings. The SSO Fellows and Young Attendings Committee tackles these topics within a three-part podcast. In this episode of SurgOnc Today, Julia Chandler, MD is joined by Dr. Helene Sterbling and Dr. Devon Freudenberger to discuss pregnancy and parenthood while in surgical training.

In this episode of Outside the OR, Dr. Russell Berman sits down with Dr. Peter Kingham to talk about the rising global cancer burden and why it matters to every surgical oncologist — and every patient.

Drawing from his extensive work in West Africa and his leadership in global surgery, Dr. Kingham shares what cancer care really looks like in low-resource settings and how individual surgeons can make a meaningful impact.

From groundbreaking research to on-the-ground challenges, this conversation shines a light on global cancer disparities.

Tune in for an eye-opening, inspiring discussion about the future of cancer care worldwide.

In this episode of SurgOnc Today, SSO Breast Disease Site Working Group members Drs. David Anderson, Fred Dirbas, and Suzanne Klimberg dive into management of male breast cancer. The speakers discuss unique considerations for this population as well as the similarities and overlap when treating female breast cancer.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Mecker G. Möller crucial questions regarding colorectal peritoneal metastasis (CRC-PM) management, particularly concerning the optimal applications of HIPEC in clinical practice, as reported in the article, "Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?"

In this episode of SurgOnc Today, Jonathan Baines, MD, Donald Warne, MD, and Lori Arviso Alvord, MD discuss advocacy and mentoring of Native American and URM Trainees.

In this episode of SurgOnc Today, Mark Knab, Charles Vining, and Kelvin Allenson discuss how the anatomic location of duodenal adenocarcinoma—from the first to the fourth portion—fundamentally shapes surgical decision-making. Discussion highlights include criteria for pancreaticoduodenectomy versus segmental or limited resections, the role of margin status and lymphadenectomy, and evolving data guiding resection strategy for non-ampullary duodenal cancers. Designed for practicing surgical oncologists, this episode emphasizes operative judgment, outcomes data, and the balance between oncologic adequacy and surgical morbidity.

In this episode of SurgOnc Today, the SSO HPB disease site working group reviews strategies for implementation of histothripsy ablation in the management of liver primary and secondary malignancies, including a discussion of the evidence supporting it and support from the IDEAL framework for the adoption of surgical innovations into clinical practice. To do so, Drs. Miral Sadaria Grandhi and Zhi Ven Fong, members of the HPB disease site working group, are joined by Drs. Hop Tran Cao, Brock Hewitt, and Jeffrey Barkun.

Drs. Kavita Vakharia, surgical oncologist from City of Hope, Dr Sara Bateni, surgical oncologist at University of Alabama at Birmingham, Dr Nikhil Khushalanai, medical oncologist at the H. Lee Moffitt Cancer Center and James Jakub, surgical oncologist at the Mayo Clinic, Florida, discuss their current practice regarding multidisciplinary management of melanoma with a focus on the role of adjuvant systemic therapy for stages IIB, IIC and IIIA disease.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Helen Johnson and Dr. Katrina Mitchell the management of patients with breast cancer diagnosed during pregnancy or lactation, and guidance provided regarding surgery, radiation, and systemic therapy, as reported in the article, "Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons."

In this episode of SurgOnc Today, Dr. Doreen Agnese, Dr. Anna C Beck and Dr. Andrea Abbott will discuss different delivery models for genetic testing, including traditional genetic testing and point of care testing. We will discuss potential pitfalls associated with point of care testing and interpretation of results.